BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29748190)

  • 1. Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors.
    Krauss T; Ferrara AM; Links TP; Wellner U; Bancos I; Kvachenyuk A; Villar Gómez de Las Heras K; Yukina MY; Petrov R; Bullivant G; von Duecker L; Jadhav S; Ploeckinger U; Welin S; Schalin-Jäntti C; Gimm O; Pfeifer M; Ngeow J; Hasse-Lazar K; Sansó G; Qi X; Ugurlu MU; Diaz RE; Wohllk N; Peczkowska M; Aberle J; Lourenço DM; Pereira MAA; Fragoso MCBV; Hoff AO; Almeida MQ; Violante AHD; Quidute ARP; Zhang Z; Recasens M; Díaz LR; Kunavisarut T; Wannachalee T; Sirinvaravong S; Jonasch E; Grozinsky-Glasberg S; Fraenkel M; Beltsevich D; Egorov VI; Bausch D; Schott M; Tiling N; Pennelli G; Zschiedrich S; Därr R; Ruf J; Denecke T; Link KH; Zovato S; von Dobschuetz E; Yaremchuk S; Amthauer H; Makay Ö; Patocs A; Walz MK; Huber TB; Seufert J; Hellman P; Kim RH; Kuchinskaya E; Schiavi F; Malinoc A; Reisch N; Jarzab B; Barontini M; Januszewicz A; Shah N; Young WF; Opocher G; Eng C; Neumann HPH; Bausch B
    Endocr Relat Cancer; 2018 Sep; 25(9):783-793. PubMed ID: 29748190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical presentation, genotype-phenotype correlations, and outcome of pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome.
    Penitenti F; Landoni L; Scardoni M; Piredda ML; Cingarlini S; Scarpa A; D'Onofrio M; Girelli D; Davi MV
    Endocrine; 2021 Oct; 74(1):180-187. PubMed ID: 34036514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous or metachronous presentation of pancreatic neuroendocrine tumor versus secondary lesion to pancreas in patients affected by renal cell carcinoma. Systematic review.
    Persano I; Parlagreco E; La Salvia A; Audisio M; Volante M; Buttigliero C; Scagliotti GV; Brizzi MP
    Semin Oncol; 2022 Dec; 49(6):476-481. PubMed ID: 36759234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients.
    Speisky D; Duces A; Bièche I; Rebours V; Hammel P; Sauvanet A; Richard S; Bedossa P; Vidaud M; Murat A; Niccoli P; Scoazec JY; Ruszniewski P; Couvelard A;
    Clin Cancer Res; 2012 May; 18(10):2838-49. PubMed ID: 22461457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and management of pancreatic neuroendocrine tumor in von Hippel-Lindau disease.
    Tamura K; Nishimori I; Ito T; Yamasaki I; Igarashi H; Shuin T
    World J Gastroenterol; 2010 Sep; 16(36):4515-8. PubMed ID: 20857520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Prognosis of Resected Pancreatic Neuroendocrine Tumors in von Hippel-Lindau Disease Is Favorable and Not Influenced by Small Tumors Left in Place.
    de Mestier L; Gaujoux S; Cros J; Hentic O; Vullierme MP; Couvelard A; Cadiot G; Sauvanet A; Ruszniewski P; Richard S; Hammel P
    Ann Surg; 2015 Aug; 262(2):384-8. PubMed ID: 25185468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine tumors of the pancreas in von Hippel-Lindau disease: spectrum of appearances at CT and MR imaging with histopathologic comparison.
    Marcos HB; Libutti SK; Alexander HR; Lubensky IA; Bartlett DL; Walther MM; Linehan WM; Glenn GM; Choyke PL
    Radiology; 2002 Dec; 225(3):751-8. PubMed ID: 12461257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic neuroendocrine tumors associated with von Hippel Lindau disease: diagnostic and management recommendations.
    Libutti SK; Choyke PL; Bartlett DL; Vargas H; Walther M; Lubensky I; Glenn G; Linehan WM; Alexander HR
    Surgery; 1998 Dec; 124(6):1153-9. PubMed ID: 9854597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease.
    Corleto VD; Cotesta D; Petramala L; Panzuto F; Pagnini C; Masoni L; Verrienti A; Delle Fave G; Filetti S; Letizia C
    JOP; 2009 Sep; 10(5):562-5. PubMed ID: 19734639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine manifestations of von Hippel-Lindau disease.
    Cassol C; Mete O
    Arch Pathol Lab Med; 2015 Feb; 139(2):263-8. PubMed ID: 25611110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Gastroenterological manifestations of von Hippel-Lindau disease - a case report].
    Koniusz J; Dąbkowski K; Buczek K; Gomółka A; Starzyńska T
    Pol Merkur Lekarski; 2017 Aug; 43(254):66-68. PubMed ID: 28875972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pancreatic neuroendocrine tumors and von Hippel-Lindau disease].
    Musso C; Paraf F; Petit B; Archambeaud-Mouveroux F; Valleix D; Labrousse F
    Ann Pathol; 2000 Mar; 20(2):130-3. PubMed ID: 10740008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation profiling in MEN1-related pancreatic neuroendocrine tumors reveals a potential epigenetic target for treatment.
    Conemans EB; Lodewijk L; Moelans CB; Offerhaus GJA; Pieterman CRC; Morsink FH; Dekkers OM; de Herder WW; Hermus AR; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Brosens LAA; Dreijerink KMA; Borel Rinkes IHM; Timmers HTM; Valk GD; Vriens MR
    Eur J Endocrinol; 2018 Sep; 179(3):153-160. PubMed ID: 29903750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features of pancreatic involvement in von Hippel-Lindau disease: a retrospective study of 55 cases in a single center.
    Park TY; Lee SK; Park JS; Oh D; Song TJ; Park DH; Lee SS; Seo DW; Kim MH
    Scand J Gastroenterol; 2015 Mar; 50(3):360-7. PubMed ID: 25562111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pancreatic tumor: unusual onset of Von-Hippel Lindau syndrome].
    Garberini A; Caricato M; Valeri S; Alloni R; Ausania F; Rosignoli A; Greco S; Rabitti C; Coppola R
    Suppl Tumori; 2005; 4(3):S56. PubMed ID: 16437901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gastroenterological manifestations of von Hippel-Lindau disease].
    Koniusz J; Dąbkowski K; Buczek K; Gomółka A; Starzyńska T
    Pol Merkur Lekarski; 2017 Aug; 43(254):53-55. PubMed ID: 28875969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of pancreatic neuroendocrine neoplasmas in Von Hippel-Lindau syndrome].
    Liu WK; Tian XD; Yang YM
    Zhonghua Wai Ke Za Zhi; 2018 Nov; 56(11):869-872. PubMed ID: 30392308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic mixed serous neuroendocrine neoplasm with clear cells leading to diagnosis of von Hippel Lindau disease.
    Kakkar A; Sharma MC; Yadav R; Panwar R; Mathur SR; Iyer VK; Sahni P
    Pathol Res Pract; 2016 Aug; 212(8):747-50. PubMed ID: 27161305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocrine pancreatic tumors in von Hippel-Lindau disease: clinical, histological, and genetic features.
    Corcos O; Couvelard A; Giraud S; Vullierme MP; Dermot O'Toole ; Rebours V; Stievenart JL; Penfornis A; Niccoli-Sire P; Baudin E; Sauvanet A; Levy P; Ruszniewski P; Richard S; Hammel P
    Pancreas; 2008 Jul; 37(1):85-93. PubMed ID: 18580449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease.
    Libutti SK; Choyke PL; Alexander HR; Glenn G; Bartlett DL; Zbar B; Lubensky I; McKee SA; Maher ER; Linehan WM; Walther MM
    Surgery; 2000 Dec; 128(6):1022-7;discussion 1027-8. PubMed ID: 11114638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.